**Bram Verstockt**, MD, Ph.D., is a consulting gastroenterologist (IBD team) in the Gastroenterology Department of the University Hospitals Leuven at KU Leuven. His translational research is focused primarily on the development of predictive and prognostic markers for a more personalized medicine in [[Inflammatory Bowel Disease|IBD]], as well as on further unraveling IBD disease heterogeneity. He co-founded the international COLLIBRI proteomics consortium in IBD. He is a member of the editorial board of the Journal of Crohn’s and Colitis, and reviewer for many gastroenterology journals and conferences. Dr. Verstockt has received several awards including the Prijs Prof. Dr. Jan De Grootte in 2013 and the Horlait-Dapsens Prize in 2020.